SWS
REGN icon

SYSTM Wealth Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

SYSTM Wealth Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$1.05K – 505
2024
Q2 		$1.05K Hold
1
– – ﹤0.01% 648
2024
Q1 		$963 Buy
+1
New +$951 ﹤0.01% 952
2023
Q1 		– Sell
-322
Closed -$232K – 514
2022
Q4 		$232K Buy
+322
New +$238K 0.03% 471

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SYSTM Wealth Solutions's REGN Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 1 share — an estimated $1.05K sold.

SYSTM Wealth Solutions first reported a position in REGN in Q4 2022 and held it in 3 quarters. The position peaked at $232K in Q4 2022. 1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 1 Regeneron Pharmaceuticals share in Q3 2024, an estimated $1.05K.
  • SYSTM Wealth Solutions first reported a position in Regeneron Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • SYSTM Wealth Solutions's Regeneron Pharmaceuticals position peaked at $232K in Q4 2022.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.